CorMedix Inc. - Common Stock (CRMD)

CUSIP: 21900C308

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Common Stock
Shares outstanding
79,310,345
Total 13F shares
23,724,937
Share change
+708,559
Total reported value
$146,235,596
Put/Call ratio
161%
Price per share
$6.16
Number of holders
135
Value change
+$397,499
Number of buys
75
Number of sells
51

Quarterly Holders Quick Answers

What is CUSIP 21900C308?
CUSIP 21900C308 identifies CRMD - CorMedix Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of CRMD - CorMedix Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock, Inc.
13D/G 13F
Company
7.5%
4,567,897
$41,659,221 $0 31 Dec 2024
VANGUARD GROUP INC
13F
Company
4.3%
3,378,191
$27,363,347 31 Dec 2024
13F
Elliott Investment Management L.P.
13F
Company
3.6%
2,870,632
$23,252,119 31 Dec 2024
13F
STATE STREET CORP
13F
Company
1.8%
1,453,148
$11,770,499 31 Dec 2024
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
1.8%
1,392,820
$11,284,215 31 Dec 2024
13F
First Turn Management, LLC
13F
Company
1.3%
1,021,421
$8,273,510 31 Dec 2024
13F
NORTHERN TRUST CORP
13F
Company
0.65%
511,565
$4,143,677 31 Dec 2024
13F
J. Goldman & Co LP
13F
Company
0.58%
457,320
$3,704,292 31 Dec 2024
13F
D. E. Shaw & Co., Inc.
13F
Company
0.56%
446,414
$3,615,953 31 Dec 2024
13F
MORGAN STANLEY
13F
Company
0.5%
398,849
$3,230,677 31 Dec 2024
13F
UBS Group AG
13F
Company
0.48%
379,868
$3,076,930 31 Dec 2024
13F
KENNEDY CAPITAL MANAGEMENT LLC
13F
Company
0.48%
378,243
$3,063,768 31 Dec 2024
13F
Palisades Investment Partners, LLC
13F
Company
0.46%
364,019
$2,948,554 31 Dec 2024
13F
GROUP ONE TRADING LLC
13F
Company
0.39%
312,081
$2,527,856 31 Dec 2024
13F
CITADEL ADVISORS LLC
13F
Company
0.37%
293,637
$2,378,460 31 Dec 2024
13F
JPMORGAN CHASE & CO
13F
Company
0.34%
273,218
$2,213,066 31 Dec 2024
13F
SIMPLEX TRADING, LLC
13F
Company
0.27%
210,356
$1,703,000 31 Dec 2024
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.25%
198,920
$1,611,253 31 Dec 2024
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.23%
178,786
$1,448,167 31 Dec 2024
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.22%
178,134
$1,442,885 31 Dec 2024
13F
Spinnaker Capital LLC
13F
Company
0.22%
175,384
$1,421,000 31 Dec 2024
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.22%
174,418
$1,412,786 31 Dec 2024
13F
Nuveen Asset Management, LLC
13F
Company
0.22%
171,978
$1,393,022 31 Dec 2024
13F
NEW YORK STATE COMMON RETIREMENT FUND
13F
Company
0.21%
167,249
$1,354,717 31 Dec 2024
13F
Steward Partners Investment Advisory, LLC
13F
Company
0.19%
149,834
$1,213,655 31 Dec 2024
13F
Erin Mistry
3/4/5
EVP, Chief Commercial Officer
mixed-class rows
200,992
mixed-class rows
$1,130,100 10 Jan 2025
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.17%
134,000
$1,085,400 31 Dec 2024
13F
David Matthew T.
3/4/5
Chief Financial Officer
mixed-class rows
195,270
mixed-class rows
$1,066,071 10 Jan 2025
Bank of New York Mellon Corp
13F
Company
0.16%
129,695
$1,050,528 31 Dec 2024
13F
Wingate Wealth Advisors, Inc.
13F
Company
0.16%
126,015
$1,020,722 31 Dec 2024
13F
RAYMOND JAMES FINANCIAL INC
13F
Company
0.15%
115,661
$936,854 31 Dec 2024
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.14%
110,782
$897,000 31 Dec 2024
13F
BARCLAYS PLC
13F
Company
0.13%
105,602
$855,376 31 Dec 2024
13F
Nicholas Investment Partners, LP
13F
Company
0.12%
94,132
$762,469 31 Dec 2024
13F
Parallax Volatility Advisers, L.P.
13F
Company
0.11%
84,461
$684,134 31 Dec 2024
13F
ExodusPoint Capital Management, LP
13F
Company
0.1%
79,289
$642,000 31 Dec 2024
13F
RHUMBLINE ADVISERS
13F
Company
0.1%
75,747
$613,542 31 Dec 2024
13F
Cubist Systematic Strategies, LLC
13F
Company
0.09%
72,354
$586,067 31 Dec 2024
13F
CITIGROUP INC
13F
Company
0.08%
63,369
$513,289 31 Dec 2024
13F
Campbell & CO Investment Adviser LLC
13F
Company
0.08%
61,352
$496,951 31 Dec 2024
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.08%
60,115
$486,931 31 Dec 2024
13F
CIBC Private Wealth Group LLC
13F
Company
0.05%
42,000
$454,020 31 Dec 2024
13F
LPL Financial LLC
13F
Company
0.07%
53,567
$433,893 31 Dec 2024
13F
Advisory Services Network, LLC
13F
Company
0.07%
51,600
$417,960 31 Dec 2024
13F
PLANNING DIRECTIONS INC
13F
Company
0.06%
50,000
$405,000 31 Dec 2024
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.06%
49,780
$403,218 31 Dec 2024
13F
Lido Advisors, LLC
13F
Company
0.06%
46,740
$378,594 31 Dec 2024
13F
DEUTSCHE BANK AG\
13F
Company
0.06%
46,660
$377,946 31 Dec 2024
13F
BALYASNY ASSET MANAGEMENT L.P.
13F
Company
0.06%
44,270
$358,587 31 Dec 2024
13F
MetLife Investment Management, LLC
13F
Company
0.05%
39,415
$319,262 31 Dec 2024
13F

Institutional Holders of CorMedix Inc. - Common Stock (CRMD) as of Q1 2025

As of 31 Mar 2025, CorMedix Inc. - Common Stock (CRMD) was held by 135 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 23,724,937 shares. The largest 10 holders included BlackRock, Inc., VANGUARD GROUP INC, Elliott Investment Management L.P., STATE STREET CORP, GEODE CAPITAL MANAGEMENT, LLC, MORGAN STANLEY, UBS Group AG, NORTHERN TRUST CORP, OBERWEIS ASSET MANAGEMENT INC/, and KENNEDY CAPITAL MANAGEMENT LLC. This page lists 136 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2025 vs Q4 2024 Across Filers

Q4 2024 holders
126
Q1 2025 holders
135
Holder diff
9
Investor Q4 2024 Shares Q1 2025 Shares Share Diff Share Chg % Q4 2024 Value $ Q1 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .